Affiliation:
1. Biocomp Group, Institute of Advanced Materials (INAM), Universitat Jaume I, 12071 Castelló de la Plana, Spain
Abstract
As more genetic information becomes available, such as DNA methylation levels, it becomes increasingly important to have techniques to analyze such data in the context of cancers such as anal and cervical carcinomas. In this paper, we present an algorithm that differentiates between healthy control patients and individuals with anal and cervical carcinoma, using as an input DNA methylation data. The algorithm used a combination of ridge regression and neural networks for the classification task, achieving high accuracy, sensitivity and specificity. The relationship between methylation levels and carcinoma could in principle be rather complex, particularly given that a large number of CpGs could be involved. Therefore, nonlinear techniques (machine learning) were used. Machine learning techniques (nonlinear) can be used to model linear processes, but the opposite (linear techniques simulating nonlinear models) would not likely generate accurate forecasts. The feature selection process is carried out using a combination of prefiltering, ridge regression and nonlinear modeling (artificial neural networks). The model selected 13 CpGs from a total of 450,000 CpGs available per patient with 171 patients in total. The model was also tested for robustness and compared to other more complex models that generated less precise classifications. The model obtained (testing dataset) an accuracy, sensitivity and specificity of 97.69%, 95.02% and 98.26%, respectively. The reduction of the dimensionality of the data, from 450,000 to 13 CpGs per patient, likely also reduced the likelihood of overfitting, which is a very substantial risk in this type of modelling. All 13 CpGs individually generated classification forecasts less accurate than the proposed model.
Funder
Spanish Ministerio de Ciencia y Tecnología
Universitat Jaume I
Subject
General Mathematics,Engineering (miscellaneous),Computer Science (miscellaneous)
Reference58 articles.
1. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001–2015;Deshmukh;JNCI J. Natl. Cancer Inst.,1991
2. Anal cancer: Emerging standards in a rare disease;Eng;J. Clin. Oncol.,2022
3. Programmed death ligand-1 expression is associated with poorer survival in anal squamous cell carcinoma;Monsrud;Arch. Pathol. Lab. Med.,2022
4. Prognosis of anal canal adenocarcinoma versus lower rectal adenocarcinoma in Japan: A propensity score matching study;Saiki;Surg. Today,2022
5. Lupi, M., Brogden, D., Howell, A., Tekkis, P., Mills, S., and Kontovounisios, C. (2022). Anal Cancer in High-Risk Women: The Lost Tribe. Cancers, 15.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献